Long-term control of carbapenemase-producing Enterobacteriaceae at the scale of a large French multihospital institution: A nine-year experience, France, 2004 to 2012

Eurosurveillance

Volumn 19, Issue 19, 2014, Pages

  Fournier, S ^a   Monteil, C ^a   Lepainteur, M ^a   Richard, C ^b   Brun Buisson, C ^c   Jarlier, V ^d   Andremont, Antoine ^e   Armand Lefevre, Laurence ^e   Birgand, Gabriel ^e   Bonnal, Christine ^e   Lucet, Jean Christophe ^e   Arlet, Guillaume ^f   Denis, Michel ^f   Baixench, Marie Thérèse ^g   Blanchard, Hervé ^g   Casetta, Anne ^g   Poupet, Hélène ^g   Barbut, Frédéric ^h   Decré, Dominique ^h   Petit, Jean Claude ^h   Berche, Patrick ⁱ   Zahar, Jean Ralph ⁱ   Bingen, Edouard ^j   Doit, Catherine ^j   Cambau, Emmanuelle ^k   Guérin, Jean Michel ^k   Raskine, Laurent ^k   Carbonne, Anne ^l   Kac, Guillaume ^l   Podglajen, Isabelle ^l   Decousser, Jean Winoc ^m   Derouin, Véronique ^m   Doucet Populaire, Florence ^m   Drieux Rouzet, Laurence ⁿ   Espinasse, Florence ^o   Heym, Beate ^o   Fortineau, Nicolas ^b   Nordmann, Patrice ^b   Herrmann, Jean Louis ^p   Lawrence, Christine ^p   Jansen, Chloé ^q   Legrand, Patrick ^q   Lesprit, Philippe ^q   Duviquet, Monique ^r   Akpabie, Anani ^s   Kassis Chikhani, Najiby ^t   Marcadé, Géraldine ^u   Fihman, Vincent ^u   Nerome, Simone ^v   Nicolas Chanoine, Marie Hélène ^v   Picard, Bertrand ^w   Seytre, Delphine ^w   Robert, Jérôme ^d   Pons, Jean Louis ^x   Rouveau, Martine ^x   Sabourin, Nadine ^a   Simon, Isabelle ^y   more..

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b BICÊTRE HOSPITAL   (France)

^c UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e BICHAT HOSPITAL   (France)

^f HÔPITAL TENON   (France)

^g NONE   (France)

^h HÔPITAL SAINT ANTOINE   (France)

ⁱ HÔPITAL NECKER ENFANTS MALADES   (France)

^j HÔPITAL ROBERT DEBRÉ   (France)

^k HÔPITAL LARIBOISIÈRE   (France)

^l HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^m HÔPITAL ANTOINE BÉCLÈRE   (France)

ⁿ HÔPITAL CHARLES FOIX   (France)

^o HÔPITAL AMBROISE PARÉ   (France)

^p RAYMOND POINCARÉ HOSPITAL   (France)

^q HENRI MONDOR HOSPITAL   (France)

^r Hôpital Vaugirard Gabriel Pallez   (France)

^s Hôpitaux Universitaires Henri Mondor   (France)

^t HÔPITAL PAUL BROUSSE   (France)

^u HÔPITAL LOUIS MOURIER   (France)

^v BEAUJON HOSPITAL   (France)

^w AVICENNE HOSPITAL   (France)

^x SAINT LOUIS HOSPITAL   (France)

^y Versailles Saint Quentin en Yvelines University   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEMASE; CEPHALOSPORIN; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; METALLO BETA LACTAMASE;

ARTICLE; BACTEREMIA; BACTERIAL TRANSMISSION; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; CITROBACTER FREUNDII; DISEASE SURVEILLANCE; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTION; ESCHERICHIA COLI; FRANCE; GENE AMPLIFICATION; GENOTYPING TECHNIQUE; HEALTH PROGRAM; HUMAN; INFECTION CONTROL; INFECTION CONTROL PRACTITIONER; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MASS SCREENING; MULTIHOSPITAL SYSTEM; NONHUMAN; RESPIRATORY TRACT INFECTION; SKIN INFECTION; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; CLINICAL LABORATORY TECHNIQUES; COMMUNICABLE DISEASES, EMERGING; CONTACT TRACING; CROSS INFECTION; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FRANCE; HOSPITALS, PUBLIC; HUMANS; MASS SCREENING; MICROBIAL SENSITIVITY TESTS; PRACTICE GUIDELINES AS TOPIC; PROGRAM EVALUATION; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 84901008825     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES2014.19.19.20802     Document Type: Article

References (29)

1. Carmeli Y, Akova M, Cornaglia G, Daikos GL, Garau J, Harbarth S, et al. Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control. Clin Microbiol Infect. 2010;16(2):102-11. http://dx.doi.org/10.1111/j.1469-0691.2009.03115.x
2. Cantón R, Akóva M, Carmeli Y, Giske CG, Glupczynski Y, Gniadkowski M, et al. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect. 2012;18(5):413-31. http://dx.doi.org/10.1111/j.1469-0691.2012.03821.x
3. Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010;10(9):597-602. http://dx.doi.org/10.1016/S1473-3099(10)70143-2
4. European Centre for Disease Prevention and Control (ECDC). Antimicrobial resistance surveillance in Europe 2011. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC; 2012. Available from: http://www.ecdc.europa.eu/en/publications/publications/antimicrobial-resistance-surveillance-europe-2011.pdf
5. Vaux S, Carbonne A, Thiolet JM, Jarlier V, Coignard B; RAISIN and Expert Laboratories Groups. Emergence of carbapenemase-producing Enterobacteriaceae in France, 2004 to 2011. Euro Surveill. 2011;16(22).
6. Kassis-Chikhani N, Saliba F, Carbonne A, Neuville S, Decre D, Sengelin C, et al. Extended measures for controlling an outbreak of VIM-1 producing imipenem-resistant Klebsiella pneumoniae in a liver transplant centre in France, 2003-2004. Euro Surveill. 2010;15(46). pii: 19713.
7. Jarlier V, Trystram D, Brun-Buisson C, Fournier S, Carbonne A, Marty L, et al. Curbing methicillin-resistant Staphylococcus aureus in 38 French hospitals through a 15-year institutional control program. Arch Intern Med. 2010;170(6):552-9. http://dx.doi.org/10.1001/archinternmed.2010.32
8. Société Française de Microbiologie (SFM). Comité de l'Antibiogramme de la Société Française de Microbiologie. [Antibiogram committee of the French Society for Microbiology]. Paris: SFM; 2013. French. Available from:http://www.resapath.anses.fr/resapath_uploadfiles/files/Documents/2013_CASFM.pdf
9. Nordmann P, Gniadkowski M, Giske CG, Poirel L, Woodford N, Miriagou V, et al. Identification and screening of carbapenemase-producing Enterobacteriaceae. Clin Microbiol Infect. 2012;18(5):432-8. http://dx.doi.org/10.1111/j.1469-0691.2012.03815.x
10. Fournier S, Lepainteur M, Kassis-Chikhani N, Huang M, Brun-Buisson C, Jarlier V. Link Between Carbapenemase-Producing Enterobacteria Carriage and Cross-Border Exchanges: Eight-Year Surveillance in a Large French Multihospitals Institution. J Travel Med. 2012;19(5):320-3. http://dx.doi.org/10.1111/j.1708-8305.2012.00641.x
11. Carbonne A, Thiolet JM, Fournier S, Fortineau N, Kassis-Chikhani N, Boytchev I, et al. Control of a multi-hospital outbreak of KPC-producing Klebsiella pneumoniae type 2 in France, September to October 2009. Euro Surveill. 2010;15(48). pii: 19734.
12. Decre D, Birgand G, Geneste D, Maury E, Petit JC, Barbut F, et al. Possible importation and subsequent cross-transmission of OXA-48-producing Klebsiella pneumoniae, France, 2010. Euro Surveill. 2010;15(46). pii: 19718.
13. Institut de veille sanitaire (InVS). Episodes impliquant des entérobactéries productrices de carbapénèmases en France. Situation épidémiologique du 3 octobre 2012. Paris: InVS. French. Available from:http://www.invs.sante.fr/Dossiers-thematiques/Maladies-infectieuses/Infections-associees-aux-soins/Surveillance-des-infections-associees-aux-soins-IAS/Enterobacteries-productrices-de-carbapenemases-EPC/Episodes-impliquant-des-enterobacteries-productrices-de-carbapenemases-en-France.-Situation-epidemiologique-du-3-octobre-2012.
14. Grundmann H, Livermore DM, Giske CG, Canton R, Rossolini GM, Campos J, et al. Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts. Euro Surveill. 2010;15(46). pii: 19711.
15. Schwaber MJ, Lev B, Israeli A, Solter E, Smollan G, Rubinovitch B, et al. Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis. 2011;52(7):848-55. http://dx.doi.org/10.1093/cid/cir025
16. Cohen MJ, Block C, Levin PD, Schwartz C, Gross I, Weiss Y, et al. Institutional control measures to curtail the epidemic spread of carbapenem-resistant Klebsiella pneumoniae: a 4-year perspective. Infect Control Hosp Epidemiol. 2011;32(7):673-8. http://dx.doi.org/10.1086/660358
17. Borer A, Eskira S, Nativ R, Saidel-Odes L, Riesenberg K, Livshiz-Riven I, et al. A multifaceted intervention strategy for eradication of a hospital-wide outbreak caused by carbapenem-resistant Klebsiella pneumoniae in Southern Israel. Infect Control Hosp Epidemiol. 2011;32(12):1158-65. http://dx.doi.org/10.1086/662620
18. Agodi A, Voulgari E, Barchitta M, Politi L, Koumaki V, Spanakis N, et al. Containment of an Outbreak of KPC-3-producing Klebsiella pneumoniae in Italy. J Clin Microbiol. 2011;49(11):3986-9. http://dx.doi.org/10.1128/JCM.01242-11
19. Kochar S, Sheard T, Sharma R, Hui A, Tolentino E, Allen G, et al. Success of an infection control program to reduce the spread of carbapenem-resistant Klebsiella pneumoniae. Infect Control Hosp Epidemiol. 2009;30(5):447-52. http://dx.doi.org/10.1086/596734
20. Fournier S, Brossier F, Fortineau N, Gillaizeau F, Akpabie A, Aubry A, et al. Long-term control of vancomycin-resistant Enterococcus faecium at the scale of a large multihospital institution: a seven-year experience. Euro Surveill. 2012;17(30). pii: 20229.
21. Struelens MJ, Monnet DL, Magiorakos AP, Santos O'Connor F, Giesecke J. New Delhi metallo-beta-lactamase 1-producing Enterobacteriaceae: emergence and response in Europe. Euro Surveill. 2010;15(46). pii: 19716.
22. Lepelletier D, Andremont A, Grandbastien B. Risk of highly resistant bacteria importation from repatriates and travelers hospitalized in foreign countries: about the French recommendations to limit their spread. J Travel Med. 2011;18(5):344-51. http://dx.doi.org/10.1111/j.1708-8305.2011.00547.x
23. Akova M, Daikos GL, Tzouvelekis L, Carmeli Y. Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria. Clin Microbiol Infect. 2012;18(5):439-48. http://dx.doi.org/10.1111/j.1469-0691.2012.03823.x
24. O'Brien DJ, Wrenn C, Roche C, Rose L, Fenelon C, Flynn A, et al. First isolation and outbreak of OXA-48-producing Klebsiella pneumoniae in an Irish hospital, March to June 2011. Euro Surveill. 2011;16(29). pii: 19921.
25. Steinmann J, Kaase M, Gatermann S, Popp W, Steinmann E, Damman M, et al. Outbreak due to a Klebsiella pneumoniae strain harbouring KPC-2 and VIM-1 in a German university hospital, July 2010 to January 2011. Euro Surveill. 2011;16(33). pii: 19944.
26. Won SY, Munoz-Price LS, Lolans K, Hota B, Weinstein RA, Hayden MK. Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Clin Infect Dis. 2011;53(6):532-40. http://dx.doi.org/10.1093/cid/cir482
27. Vatopoulos A. High rates of metallo-beta-lactamase-producing Klebsiella pneumoniae in Greece--a review of the current evidence. Euro Surveill. 2008;13(4). pii: 8023.
28. Harris AD, Bradham DD, Baumgarten M, Zuckerman IH, Fink JC, Perencevich EN. The use and interpretation of quasi-experimental studies in infectious diseases. Clin Infect Dis. 2004;38(11):1586-91. http://dx.doi.org/10.1086/420936
29. Schwaber MJ, Carmeli Y. Carbapenem-resistant Enterobacteriaceae: a potential threat. JAMA. 2008;300(24):2911-3. http://dx.doi.org/10.1001/jama.2008.896